HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

Novel PCR Testing Device Represents Technological Leap in POC Infectious Disease Diagnostics

By HospiMedica International staff writers
Posted on 15 May 2023
Image: The Nuclein Anywhere PCR Test is designed to offer a simple PCR to test for infectious disease (Photo courtesy of Nuclein)
Image: The Nuclein Anywhere PCR Test is designed to offer a simple PCR to test for infectious disease (Photo courtesy of Nuclein)

Testing for infectious diseases is vital for global health. Present testing methods, including immunochemistry and nucleic acid detection, play a crucial role in combating infectious diseases, but they also have significant drawbacks. Consequently, healthcare providers and patients often have to choose between fast and affordable results with limited sensitivity, or slower, more accurate results which often arrive too late to significantly impact outcomes. This situation often leads to lost opportunities for more effective treatment of infectious diseases. Now, a novel testing device offers a significant advancement in point-of-care infectious disease testing, potentially expanding the scope of telemedicine interactions between healthcare professionals and their patients.

Nuclein’s (Austin, TX, USA) Anywhere PCR Test is a PCR testing device designed to run a real-time PCR reaction inside an all-in-one self-test, infectious disease testing solution and delivers battery-powered, sample-to-answer results in less than an hour. This allows immediate, self-testing results to be available anywhere at the push of a button, utilizing the same standard real-time PCR technology employed by the U.S. Centers for Disease Control and Prevention (CDC), other government bodies, and commercial laboratories.

The testing device is designed to accept a saliva sample directly from the patient. The diagnostic process can be initiated by simply pressing a button, after which the device automatically prepares the sample for analysis. Test results are then automatically displayed on the LCD screen within an hour, indicating either a negative or positive result. The capacity to provide immediate results in less than an hour potentially makes the Nuclein Anywhere PCR Test an exceptionally useful tool for detecting infectious diseases, facilitating faster and more informed decision-making, ultimately leading to improved outcomes.

Related Links:
Nuclein 

Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Adjustable Mobile Barrier
M-458
Pressure Guidewire
SavvyWire

Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more